Zhongchao

ZCMD

Capitalización de mercado USD 5.81 M

SHANGHAI, Sept. 30, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-2 share consolidation of the Company's ordinary shares of US$0.744 par value each (the "Share Consolidation").

SHANGHAI, July 23, 2026 /PRNewswire/ -- Zhongchao Inc ("Zhongchao" or the "Company") (NASDAQ: ZCMD), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 4,545,455 of the Company's Class A Ordinary Shares, par value $0.744 per share (the "Shares") (or pre-funded warrants in lieu thereof) at a purchase price of $1.10 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $ 0.001 per share.

SHANGHAI, June 25, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-3 share consolidation of the Company's ordinary shares of US$0.248 par value each (the "Share Consolidation"). Beginning with the opening of trading on June 29, 2026, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD," but under a new CUSIP number of G9897X149.

SHANGHAI, June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-31 share consolidation of the Company's ordinary shares of US$0.008 par value each (the "Share Consolidation"). Beginning with the opening of trading on June 8, 2026, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD," but under a new CUSIP number of G9897X131.

SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the pricing of a best efforts public offering with gross proceeds to the Company expected to be approximately $5 million, before deducting placement agent fees and other estimated expenses payable by the Company, excluding the exercise of any warrant offered. The offering is comprised of 9,259,260 units (each a "Unit"), each consisting of one Class A ordinary share of the Company, par value $0.008 per share (the "Class A ordinary shares"), or in lieu thereof, a pre-funded warrant, and one warrant to purchase one Class A ordinary share (each, a "Warrant").

SHANGHAI, Feb. 26, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-8 share consolidation of the Company's ordinary shares of US$0.001 par value each (the "Share Consolidation"). Beginning with the opening of trading on March 2, 2026, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD", but under a new CUSIP number of G9897X123.

Zhongchao (NASDAQ: ZCMD ) stock is on the rise Wednesday alongside heavy pre-market trading of the healthcare information company's shares. This has more than 12 million shares of ZCMD stock changing hands as of this writing.

Zhongchao (NASDAQ: ZCMD ) stock is rocketing higher on Friday alongside heavy trading of the Chinese healthcare information and training company's shares. That has more than 11.9 million shares of ZCMD stock changing hands as of this writing.

Zhongchao (NASDAQ: ZCMD ) stock is soaring higher on Thursday alongside heavy pre-market trading of the Chinese healthcare information, education and training services company's shares. This has more than 5.3 million shares of ZCMD stock changing hands as of this writing.

SHANGHAI , March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, had successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE) and reduced their financial challenges associated with long-term treatment.